The Global Nicorandil API Market was valued at US$ 75.4 Million in 2025 and is projected to reach US$ 101.2 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period (2024–2030). This growth is being driven by a rising global burden of cardiovascular diseases, increased generic drug production, and heightened pharmaceutical industry focus on angina pectoris and related ischemic heart condition treatments.

At the core of this critical therapeutic area are the Active Pharmaceutical Ingredient (API) manufacturers who ensure a consistent, high-quality supply of Nicorandil to formulation companies worldwide. In this blog, we profile the Top 10 Companies in the Nicorandil API Industry—a diverse mix of established pharmaceutical conglomerates and specialized API producers shaping the supply chain for this essential cardiovascular drug.

Download FREE Sample Report:
Nicorandil API Market – View in Detailed Research Report

---

🔟 1. Tianfang Pharmaceutical

Headquarters: Shenzhen, China
Key Offering: High Purity (>99%) Nicorandil API, cGMP Compliant Materials

Tianfang Pharmaceutical is a major supplier in the global pharmaceutical chemical market, with significant production capabilities for cardiovascular APIs. Their Nicorandil API is manufactured under strict international quality standards, serving both domestic Chinese formulation companies and export markets across Asia and Europe.

Key Strengths & Initiatives:

• Vertically integrated production with control over key raw materials

• Investment in advanced purification and crystallization technologies to enhance yield and purity

• Active in DMF (Drug Master File) filings in key regulated markets to support client approvals

---

9️⃣ 2. Yangzijiang Pharmaceutical Group (Jiangsu Haici Biological Pharmaceutical Co., Ltd.)

Headquarters: Taizhou, Jiangsu, China
Key Offering: Nicorandil API for Injectable and Oral Dosage Forms

As part of the renowned Yangzijiang Pharmaceutical Group, the Haici Biological subsidiary leverages the group’s extensive R&D and manufacturing infrastructure. It is a prominent player in the cardiovascular API space, known for its reliable and scalable supply chain for Nicorandil.

Key Strengths & Initiatives:

• Advanced biocatalysis and green chemistry initiatives to optimize the synthesis process of Nicorandil

• Strategic focus on high-barrier-to-entry APIs with complex synthesis pathways

• Robust quality management systems certified by multiple international regulatory bodies

---

8️⃣ 3. Xi’an Libang Pharmaceutical

Headquarters: Xi’an, Shaanxi, China
Key Offering: cGMP Nicorandil API, Customized Particle Size Distribution

Xi’an Libang Pharmaceutical specializes in the research, development, and production of niche APIs, with a stronghold in cardiology and central nervous system segments. The company provides highly pure Nicorandil API tailored to meet specific formulation requirements of its global partners.

Key Strengths & Initiatives:

• State-of-the-art analytical laboratories for comprehensive impurity profiling and stability studies

• Strong focus on process development to reduce production costs and environmental impact

• Active collaboration with academic institutions for next-generation synthetic route development

---

7️⃣ 4. Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmacopoeia Standard (USP, EP, JP) Nicorandil API

Located in China’s major pharmaceutical hub, Shanghai Xudong Haipu has emerged as a key supplier of high-grade pharmaceutical intermediates and APIs. Their Nicorandil API is produced to meet the stringent specifications of various international pharmacopoeias, ensuring global compliance.

Key Strengths & Initiatives:

• Dedicated high-potency API (HPAPI) manufacturing facilities with stringent containment controls

• Commitment to sustainable manufacturing with waste-reduction programs

• Integrated supply chain providing key starting materials for Nicorandil synthesis

Download FREE Sample Report:
Nicorandil API Market – View in Detailed Research Report

---

6️⃣ 5. Nanjing Jinglun Pharmaceutical

Headquarters: Nanjing, Jiangsu, China
Key Offering: Nicorandil API, Pharmaceutical Intermediates for Cardiovascular Drugs

Nanjing Jinglun Pharmaceutical is a technology-driven enterprise with significant investments in process chemistry. The company’s expertise in heterocyclic compound synthesis, a core component of Nicorandil’s structure, positions it as a critical and knowledgeable supplier in this market.

Key Strengths & Initiatives:

• Proprietary catalytic processes to improve the efficiency of key reaction steps

• Comprehensive regulatory support team assisting clients with audit and documentation

• Diversified product portfolio mitigating reliance on single products and ensuring business stability

---

5️⃣ 6. China Resources Double Crane Pharmaceutical

Headquarters: Beijing, China
Key Offering: Nicorandil API and Finished Dosage Forms (Injection, Tablets)

As a subsidiary of the massive China Resources group, this company operates with significant financial and infrastructural backing. It boasts a rare, fully integrated model, producing the Nicorandil API and formulating it into various finished drugs, granting deep insights into the entire product lifecycle.

Key Strengths & Initiatives:

• Vertical integration offers superior control over quality from API synthesis to final product packaging

• Extensive domestic distribution network within China, a key growth market for cardiovascular therapeutics

• Substantial investment in new production lines to increase capacity and meet rising demand

---

4️⃣ 7. Changchun Dazheng Pharmaceutical

Headquarters: Changchun, Jilin, China
Key Offering: High-Purity Nicorandil, Custom Synthesis Services

Changchun Dazheng Pharmaceutical combines expertise in chemical synthesis with modern biocatalytic methods. The company focuses on producing APIs with excellent crystalline form and consistent polymorphic characteristics, which are crucial for the stability and bioavailability of the final drug product.

Key Strengths & Initiatives:

• Focus on crystal engineering to offer APIs with optimized physical properties for formulation

• Adoption of continuous manufacturing technologies for more consistent and efficient production

• Strong IP strategy to protect proprietary manufacturing processes

---

3️⃣ 8. Mudanjiang Lingtai Pharmaceutical

Headquarters: Mudanjiang, Heilongjiang, China
Key Offering: Cost-Competitive Nicorandil API, Bulk Supply

Strategically located in a region with a strong chemical industry base, Mudanjiang Lingtai Pharmaceutical leverages access to raw materials and energy to produce economically efficient APIs. It is a key supplier for generic drug manufacturers globally who prioritize a reliable and cost-effective supply chain.

Key Strengths & Initiatives:

• Economies of scale in procurement and production, leading to competitive pricing

• Strategic partnerships with logistical firms ensuring efficient and reliable global delivery

• Ongoing facility modernization to meet evolving international environmental and safety standards

---

2️⃣ 9. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.

Headquarters: Guangzhou, Guangdong, China
Key Offering: Branded and Generic Nicorandil API, Contract Manufacturing

As a member of the prestigious Guangzhou Baiyunshan group, one of China’s oldest and largest pharmaceutical manufacturers, Mingxing Pharmaceutical carries a legacy of trust and quality. The company supplies API for both its own branded formulations and to external clients, adhering to rigorous internal standards.

Key Strengths & Initiatives:

• Strong brand reputation and long-standing relationships within the global pharmaceutical industry

• Focus on “high-value” APIs that require complex multi-step synthesis, such as Nicorandil

• Investment in digital manufacturing systems (Industry 4.0) for enhanced process control and data integrity

---

1️⃣ 10. Jiangsu Pingguang Pharmaceutical

Headquarters: Yancheng, Jiangsu, China
Key Offering: Nicorandil API, Advanced Pharmaceutical Intermediates

Jiangsu Pingguang is recognized for its specialized chemical synthesis and fine chemical capabilities. The company’s approach to Nicorandil production emphasizes process robustness and scalability, making it a dependable partner for large-scale, long-term supply agreements.

Key Strengths & Initiatives:

• Expertise in handling sensitive chemical reactions under controlled conditions, critical for Nicorandil’s pyridine and nitrate ester functional groups

• Comprehensive environmental, health, and safety (EHS) management systems that exceed local compliance requirements

• Proactive approach to regulatory changes, ensuring continuous market access for clients

Get Full Report Here:
Nicorandil API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Nicorandil API Is Driven by Precision and Globalization

The Nicorandil API market is experiencing a strategic evolution. While generic competition shapes pricing, the emphasis is shifting towards manufacturers who can deliver uncompromising quality, regulatory agility, and innovative process technologies.

📈 Key Trends Shaping the Market:

• Increasing regulatory scrutiny on impurity profiles (genotoxic impurities, nitrosamines) driving advanced analytical investments among API producers

• Growing demand from emerging pharmaceutical markets in Asia-Pacific, Latin America, and the Middle East & Africa creating new supply chain dynamics

• Adoption of continuous manufacturing and flow chemistry for improved efficiency, safety, and product consistency in API synthesis

• Strategic consolidation and partnerships between API manufacturers and finished dosage form companies to secure supply chains and co-develop improved formulations

Get Full Report Here:
Nicorandil API Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical pharmaceutical ingredient—they are enabling global access to affordable and effective cardiovascular therapy, underpinning the health of millions of patients worldwide.